Articles Tagged with ''Qorvo''

Qorvo^® announced that the U.S. Food and Drug Administration (FDA) has granted emergency use authorization (EUA) for the Qorvo Omnia™ COVID-19 Antigen Test in point-of-care (POC) settings.

Qorvo^® has been selected by the DOD to proceed with the Advanced Integration Interconnection and Fabrication Growth for Domestic State of the Art (SOTA) RF GaN program, also known as STARRY NITE, as part of the Office of Undersecretary of Defense Research & Engineering's (OUSD R&E) microelectronics roadmap.

Qorvo® announced the QPA3908 and QPA3810, two GaN 8 W power amplifier modules (PAMs) that offer a combination of high performance and a significantly smaller footprint than traditional discrete component solutions.

Qorvo announced the availability of the ACT41000-104-REF1, a GaN power amplifier (PA) biasing reference design that enhances the design and testing of Qorvo’s GaN PAs.

Qorvo announced a 20 W GaN-on-SiC power amplifier (PA) for defense and commercial satellite applications, including low Earth orbit constellations.

The QPA1724 provides 20 W of saturated power from 17.3 to 21.2 GHz for radar applications in both commercial and military markets.

The QPF4506B integrates a 5 GHz power amplifier, regulator, single pole two throw switch, bypassable low noise amplifier and coupler into a single device for Wi-Fi 802.11ax systems.